Clinical Trial Update: A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) [NA]

View source ↗

Summary

AIMSS is a study investigating genetic predictors of aromatase inhibitor–associated musculoskeletal symptoms in breast cancer; the trial is active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-24